Acadia Pharmaceuticals

3 Biotech Stocks That Soared Last Week
3 Biotech Stocks That Soared Last Week
Motley Fool
Acadia Pharmaceuticals
Nuplazid
Mesoblast
Grunenthal
MPC-06-ID
Kodiak Sciences
age-related macular degeneration
Flag link:
Acadia calls early halt to Nuplazid psychosis trial after promising interim results
Acadia calls early halt to Nuplazid psychosis trial after promising interim results
Fierce Pharma
Acadia Pharmaceuticals
Nuplazid
dementia-related psychosis
Flag link:
Trial win could drive Acadia's Nuplazid to new use
Trial win could drive Acadia's Nuplazid to new use
Biopharma Dive
Acadia Pharmaceuticals
Nuplazid
dementia-related psychosis
clinical trials
FDA
Flag link:
Upcoming events – Acadia hopes for new indications for Nuplazid
Upcoming events – Acadia hopes for new indications for Nuplazid
EP Vantage
Acadia Pharmaceuticals
antipsychotics
Nuplazid
schizophrenia
dementia
Flag link:
Acadia to Move Experimental Pediatric Rett Syndrome Drug to Phase 3
Acadia to Move Experimental Pediatric Rett Syndrome Drug to Phase 3
Xconomy
Acadia Pharmaceuticals
pediatrics
Rett Syndrome
clinical trials
trofinetide
Flag link:
Justice Department launches probe into Acadia's Nuplazid marketing
Justice Department launches probe into Acadia's Nuplazid marketing
Fierce Pharma
Acadia Pharmaceuticals
Nuplazid
DOJ
drug marketing
Flag link:
Follow-on roundup: Acadia raises $275M, Rocket pockets $55M
Follow-on roundup: Acadia raises $275M, Rocket pockets $55M
BioCentury
Acadia Pharmaceuticals
Rocket Pharmaceuticals
Flag link:
3 Biotech Stocks That Soared This Week
3 Biotech Stocks That Soared This Week
Motley Fool
Viking Therapeutics
Acadia Pharmaceuticals
Corbus Pharmaceuticals
Flag link: